Litcius/Paper detail

Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome

Cheng Chang, Yilong Pan, Hongjiao Du, Xiao Wang, Xiaodong Li

2020Clinical Biochemistry14 citationsDOI

Topics & Concepts

MedicineBiomarkerAcute coronary syndromeInternal medicineCoronary artery diseaseGastroenterologySerum amyloid ACoronary angiographyScadAcute-phase proteinCardiologyInflammationMyocardial infarctionBiochemistryChemistryAmyloidosis: Diagnosis, Treatment, OutcomesAlzheimer's disease research and treatmentsParathyroid Disorders and Treatments
Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome | Litcius